Print

Oramed Pharmaceuticals Inc. (ORMP.OB) Awarded Grant by the Office of the Chief Scientist of Israel  
5/8/2012 10:19:54 AM

JERUSALEM--(BUSINESS WIRE)--Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant amounting to a net sum of NIS 2 million (approximately $540,000), from the Office of the Chief Scientist (“OCS”) at the Ministry of Industry, Trade and Labor of Israel. The funds will be designated and used by Oramed Ltd. to support further R&D and clinical studies on its oral insulin capsule and oral GLP-1 analog from December 2011 to November 2012.
//-->